ZimVie Inc (ZIMV)
16.79
+0.07
(+0.42%)
USD |
NASDAQ |
May 24, 11:28
ZimVie Cash from Financing (TTM): -16.17M for March 31, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | -16.17M |
| December 31, 2023 | -25.67M |
| September 30, 2023 | -33.30M |
| June 30, 2023 | -29.81M |
| March 31, 2023 | -34.39M |
| Date | Value |
|---|---|
| December 31, 2022 | -1.307M |
| September 30, 2022 | 95.10M |
| June 30, 2022 | 121.02M |
| March 31, 2022 | 101.84M |
| December 31, 2021 | 72.35M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-34.39M
Minimum
Mar 2023
121.02M
Maximum
Jun 2022
24.97M
Average
-8.737M
Median
Cash from Financing (TTM) Benchmarks
| Orthofix Medical Inc | 70.79M |
| Stryker Corp | -1.531B |
| Globus Medical Inc | -350.48M |
| Paragon 28 Inc | 58.02M |
| Perspective Therapeutics Inc | 167.19M |